Is an Enlarged Heart a Problem of Toxic Metal Exposure?
Over the last few years, the Magazine Center for Wellness has participated in research surrounding the use of EDTA chelation for patients with cardiovascular problems. These problems include past heart attacks and advanced coronary disease which may make the patient physically ineligible for cardiovascular surgery. EDTA Chelation therapy has also been and is being examined as an option for patients who do not want to undergo cardiac surgical procedures.To get more news about Buy emeramide, you can visit fandachem.com official website.
Chelation involves the intravenous infusion of vitamins, magnesium and a chelating agent, ethylene diamine tetra-acetic acid (EDTA).
This mixture serves to chelate, or bind, toxic heavy metals, calcium and free radicals in blood vessel walls, which are then excreted in the urine. As a result, blood vessels become more pliable and circulation improves, which leads to the reduction or elimination of chest pain and other symptoms of vascular disease. Patients who have completed a course of chelation therapy often notice an improvement in energy and well-being, and are often able to reduce or eliminate their need for medication.
We have offered this treatment for more than 30 years. In 2012 the Magaziner Center for Wellness was chosen to participate in a study through the National Institutes of Health to test the effectiveness of EDTA chelation in patients suffering from heart disease. The study was called TACT, The Trial to Assess Chelation Therapy.(1)
In this article we will examine a portion of the findings of this study and other research that examines the role of toxic/heavy metals in accelerating and causing the problems of heart disease.August 2018 – Doctors at the Department of Public Health and Primary Care, University of Cambridge published research in the British Medical Journal (4) that found: “Exposure to arsenic, lead, cadmium, and copper is associated with an increased risk of cardiovascular disease and coronary heart disease. Mercury is not associated with cardiovascular risk. These findings reinforce the importance of environmental toxic metals in cardiovascular risk, beyond the roles of conventional behavioral risk factors.” (There is controversy, as presented in other studies as to the exact role of mercury in cardiovascular risk. One of the controversies surrounds the amounts of mercury present in seafood. As pointed out in an editorial response (5) to this research which we will also cite below: “Methylmercury contamination of fish is the primary source of mercury in most populations and these null results must be interpreted carefully.”)
May 2019 – A study lead by Columbia University in New York (6) examined arsenic exposure and its possible relationship to numerous adverse cardiovascular outcomes. The researchers here investigated the association between arsenic exposure and left ventricular function. (That portion of your heart that pumps the blood to the rest of your body). What you may find interesting is that the group they tested were young American Indians with a low burden of cardiovascular risk factors. Here are the concerning results:
ความคิดเห็น